Larger pharmaceutical companies generally kept their net gains in a modest range, with companies between $10-200B in market cap seeing gains within the range of +.5-1% while medium sized companies in... Read More
from Bio-Wire.Com
Although the relationship between pharmaceutical companies and doctors is widely accepted, researchers from Oregon State University, Oregon Health & Science University and the University of Washington... Read More
from Financial Content
Investors Begin To Realize RNA’s Potential
May 21, 2013
from ACCESSWIRE
Charting a persistent May uptrend
May 21, 2013
The major U.S. stock benchmarks have knifed to less-charted territory, and the technical price action is holding true to form. Read More
from MarketWatch
Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR
May 21, 2013
from ACCESSWIRE
Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
May 21, 2013
from ACCESSWIRE
Notable Analyst Rating Changes 05/21: (CNQ) (CBST) (WTSL) Upgraded; (CCL) (DB) (COH) Downgraded
May 21, 2013
Upgrade Alert for Cubist Pharmaceuticals (CBST)
May 21, 2013
A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . Read More
from FOX News
May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin... Read More
category
companyNews
Interesting OPK Put And Call For July
May 20, 2013
Investors in Opko Health Inc (OPK) saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the... Read More
category
Stocks
from Market News Video
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive... Read More
category
companyNews
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
from Bio-Wire.Com
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity... Read More
from Bio-Wire.Com
In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were... Read More
from ChinaBio® Today
Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013
from ACCESSWIRE
May 20 (Reuters) - Generic drugmaker Actavis Inc, itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc for $5 billion in stock to... Read More
category
companyNews
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here